Substance Abuse and PregnancyPharmacologic Management of Neonatal Abstinence Syndrome in a Community HospitalNAPOLITANO, ANTHONY MD*; THEOPHILOPOULOS, DEAN MD†; SENG, SARA K. PharmD‡; CALHOUN, DARLENE A. MS, DO†Author Information *All Children’s Hospital, West Coast Neonatology, Sarasota Memorial Hospital, St Petersburg, Florida; †All Children’s Hospital, Sarasota Memorial Hospital, Sarasota, Florida; ‡Department of Pharmaceutical Care Services, All Children’s Hospital, Sarasota Memorial Hospital, Sarasota, Florida The authors declare that they have nothing to disclose. Correspondence: Anthony Napolitano, MD, All Children’s Hospital, West Coast Neonatology-All Children’s Specialty Physicians, Medical Director NICU, Sarasota Memorial Hospital, 501 6th Ave. South 5th Floor Dept 7565, St Petersburg, FL. E-mail: firstname.lastname@example.org Clinical Obstetrics and Gynecology: March 2013 - Volume 56 - Issue 1 - p 193-201 doi: 10.1097/GRF.0b013e31827adf91 Buy SDC Metrics Abstract Neonatal abstinence syndrome has become a growing concern in infants born to substance-abusing mothers in the State of Florida. At Sarasota Memorial Hospital in Sarasota, FL, methadone and morphine treatment strategies have been formulated to manage symptomatic neonates after birth. We report our findings over a 5-year period utilizing each of these protocols in a community hospital setting. © 2013 Lippincott Williams & Wilkins, Inc.